Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.
Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J. Jung C, et al. Among authors: gonon at. Cardiovasc Res. 2010 Jan 1;85(1):147-54. doi: 10.1093/cvr/cvp303. Cardiovasc Res. 2010. PMID: 19726439
The novel non-peptide selective endothelin A receptor antagonist LU 135,252 protects against myocardial ischaemic and reperfusion injury in the pig.
Gonon AT, Wang QD, Shimizu M, Pernow J. Gonon AT, et al. Acta Physiol Scand. 1998 Jun;163(2):131-7. doi: 10.1046/j.1365-201X.1998.00376.x. Acta Physiol Scand. 1998. PMID: 9648631
Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig.
Källner G, Gonon A, Franco-Cereceda A. Källner G, et al. Cardiovasc Res. 1998 May;38(2):493-9. doi: 10.1016/s0008-6363(98)00016-9. Cardiovasc Res. 1998. PMID: 9709411
Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition.
Wang QD, Gonon A, Shimizu M, Sjöquist PO, Pernow J. Wang QD, et al. Acta Physiol Scand. 1998 Aug;163(4):325-30. doi: 10.1046/j.1365-201X.1998.t01-1-00364.x. Acta Physiol Scand. 1998. PMID: 9789575
The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
Gonon AT, Wang QD, Pernow J. Gonon AT, et al. Cardiovasc Res. 1998 Sep;39(3):674-82. doi: 10.1016/s0008-6363(98)00167-9. Cardiovasc Res. 1998. PMID: 9861311
Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine.
Segawa D, Sjöquist PO, Nordlander M, Wang QD, Gonon A, Rydén L. Segawa D, et al. Eur J Pharmacol. 1999 Sep 10;380(2-3):123-8. doi: 10.1016/s0014-2999(99)00528-2. Eur J Pharmacol. 1999. PMID: 10513571
Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine.
Segawa D, Sjöquist PO, Wang QD, Gonon A, Nordlander M, Rydén L. Segawa D, et al. J Cardiovasc Pharmacol. 2000 Sep;36(3):338-43. doi: 10.1097/00005344-200009000-00009. J Cardiovasc Pharmacol. 2000. PMID: 10975591
Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
Gonon AT, Gourine AV, Pernow J. Gonon AT, et al. J Cardiovasc Pharmacol. 2000 Sep;36(3):405-12. doi: 10.1097/00005344-200009000-00018. J Cardiovasc Pharmacol. 2000. PMID: 10975600
Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion.
Gourine AV, Gonon AT, Pernow J. Gourine AV, et al. Among authors: gonon at. Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1105-12. doi: 10.1152/ajpheart.2001.280.3.H1105. Am J Physiol Heart Circ Physiol. 2001. PMID: 11179053
Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium.
Gourine A, Gonon A, Sjöquist PO, Pernow J. Gourine A, et al. Cardiovasc Res. 2001 Jul;51(1):100-7. doi: 10.1016/s0008-6363(01)00280-2. Cardiovasc Res. 2001. PMID: 11399252
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback